DiscoverQuantum AI InstituteQuantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda
Quantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda

Quantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda

Update: 2021-12-28
Share

Description

The Quantum AI Series features exclusive interviews of the global innovators shaping the future of quantum computing. In Episode 4 of Season 2, Maëva Ghonda, the founder and chair of the Quantum AI Institute, interviews Dr. Hans Melo, CEO, Menten AI.


Dr. Hans Melo is co-founder and CEO of Menten AI, Inc., a therapeutics company and leader in quantum computing applications in drug discovery. He holds a PhD in Machine Learning and Computational Neuroscience from the University of Toronto.


Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We develop computational methods for protein design that leverage machine learning and quantum computing.

Comments 
In Channel
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Quantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda

Quantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda

Quantum AI Institute